Bank of New York Mellon Corp Sells 47,707 Shares of Encompass Health Co. (NYSE:EHC)

Bank of New York Mellon Corp lessened its holdings in Encompass Health Co. (NYSE:EHC) by 3.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,315,320 shares of the company’s stock after selling 47,707 shares during the period. Bank of New York Mellon Corp owned approximately 1.31% of Encompass Health worth $121,470,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the business. State Street Corp increased its position in Encompass Health by 0.7% in the third quarter. State Street Corp now owns 3,025,769 shares of the company’s stock worth $292,410,000 after purchasing an additional 21,329 shares during the last quarter. Geode Capital Management LLC increased its position in Encompass Health by 1.2% in the third quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock worth $161,781,000 after purchasing an additional 20,547 shares during the last quarter. Copeland Capital Management LLC increased its position in Encompass Health by 0.7% in the fourth quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company’s stock worth $119,418,000 after purchasing an additional 8,548 shares during the last quarter. Point72 Asset Management L.P. increased its position in Encompass Health by 2,458.5% in the third quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock worth $83,990,000 after purchasing an additional 835,135 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. increased its position in Encompass Health by 0.4% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 769,716 shares of the company’s stock worth $71,083,000 after purchasing an additional 2,904 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Insider Buying and Selling

In related news, CAO Andrew L. Price sold 5,042 shares of the company’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.10% of the stock is owned by insiders.

Analyst Ratings Changes

Several brokerages recently weighed in on EHC. Royal Bank of Canada restated an “outperform” rating and issued a $110.00 price target on shares of Encompass Health in a research report on Tuesday, February 11th. StockNews.com raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. KeyCorp lifted their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Monday, February 10th. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Finally, Barclays lifted their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, February 7th. Ten research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Encompass Health currently has an average rating of “Buy” and an average price target of $107.67.

Encompass Health Stock Down 0.2 %

Shares of EHC opened at $100.11 on Friday. The firm has a market capitalization of $10.09 billion, a P/E ratio of 22.45, a P/E/G ratio of 2.31 and a beta of 0.90. Encompass Health Co. has a 12-month low of $73.68 and a 12-month high of $104.55. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. The firm has a fifty day moving average price of $96.42 and a 200-day moving average price of $96.36.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Equities research analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 17th. Investors of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.68%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health’s dividend payout ratio (DPR) is presently 15.25%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.